Trials / Terminated
TerminatedNCT03926637
Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis
Feasibility of the Multiple Sclerosis Performance Test for Assessment of Functional Performance Measures in Patients With Multiple Sclerosis
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,073 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the feasibility of the Multiple Sclerosis Performance Test (MSPT) in a clinical care setting when used by participants with Multiple Sclerosis (MS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Multiple Sclerosis Performance Test (MSPT) | Administered as specified in the treatment arm. |
Timeline
- Start date
- 2019-06-17
- Primary completion
- 2022-12-05
- Completion
- 2022-12-05
- First posted
- 2019-04-24
- Last updated
- 2023-01-30
Locations
33 sites across 6 countries: United States, Czechia, France, Italy, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT03926637. Inclusion in this directory is not an endorsement.